Individualized Nursing Care: Participants in this group receive structured, personalized nursing care sessions, including targeted education, individual goal-setting, self-monitoring guidance, and ongoing follow-up to enhance diabetes self-management.
Study summary
This randomized controlled trial aims to evaluate the effects of individualized nursing care interventions on self-efficacy, empowerment, and self-management behaviors in individuals diagnosed with diabetes. Diabetes requires lifelong management, and standard care approaches often fall short of meeting individual psychosocial and clinical needs. By implementing structured, patient-centered nursing care protocols, this study assesses how personalized education, follow-up, and support mechanisms influence patients' capacity to manage their condition, improve glycemic control, and enhance their overall quality of life.
Eligibility
Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria:
* Diagnosed with diabetes (Type 1 or Type 2)
* Age 18 years or older
* Able to communicate in Turkish and cooperate with the study requirements
* Voluntarily willing to participate and sign the informed consent form
Exclusion Criteria:
* Having severe cognitive impairment, psychiatric disorders, or communication barriers that prevent participation
* Having severe terminal illnesses or acute medical complications that interfere with follow-up
Primary outcome measure(s)
Adult Diabetes Knowledge Score — Baseline and 3 months Change in adult diabetes knowledge score as measured by the Adult Diabetes Knowledge Scale (ADKS) from baseline to 3 months. (Total score ranging from 0 to 28 points).
Diabetes Self-Management Behaviors Score — Baseline and 3 months Change in diabetes self-management score as measured by the Diabetes Self-Management Questionnaire (DSMQ) from baseline to 3 months. (Total and subscale points).
Diabetes Empowerment and Psychosocial Self-Efficacy Score — Baseline and 3 months Change in diabetes empowerment score as measured by the Diabetes Empowerment Scale (DES) from baseline to 3 months. (Likert scale points ranging from 0 to 5).
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time.